NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-205 Cr | ₹-186 Cr | ₹-119 Cr | ₹11 Cr | ₹-252 Cr |
What is the latest Cash Flow from Financing Activities ratio of NECTAR LIFESCIENCES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-205 Cr |
Mar2023 | ₹-186 Cr |
Mar2022 | ₹-119 Cr |
Mar2021 | ₹11 Cr |
Mar2020 | ₹-252 Cr |
How is Cash Flow from Financing Activities of NECTAR LIFESCIENCES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-205 Cr | Negative | |
Mar2023 | ₹-186 Cr | Negative | |
Mar2022 | ₹-119 Cr | Negative | |
Mar2021 | ₹11 Cr | Positive | |
Mar2020 | ₹-252 Cr | - |
Compare Cash Flow from Financing Activities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹399.7 Cr | -5.9% | -14.8% | -40.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | -5.9% |
-14.8% |
-40.4% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses